Question 1

Who are the top researchers at Affibody (Sweden)?

Accepted Answer

Ranked on the quality score, Joachim Feldwisch, Fredrik Y. Nilsson and Ingmarie Höidén‐Guthenberg lead among researchers whose main affiliation is Affibody (Sweden).

Question 2

What are the most cited papers from Affibody (Sweden)?

Accepted Answer

The most cited paper from Affibody (Sweden) is "Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications" (John Löfblom, Joachim Feldwisch, Vladimir Tolmachev et al., 2010), with 657 citations. Next come "Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule" (574) and "Protein A chromatography for antibody purification" (561).

Question 3

Which research topics does Affibody (Sweden) publish most on?

Accepted Answer

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications, HER2/EGFR in Cancer Research and CAR-T cell therapy research.

Question 4

Which keywords describe research at Affibody (Sweden)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, PET Imaging, Targeted Therapy and Cancer Treatment.

Question 5

Which fields of science does Affibody (Sweden) work in?

Accepted Answer

In all years, 65% of research at Affibody (Sweden) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (65%), Biochemistry, Genetics and Molecular Biology (26%), Immunology and Microbiology (3%). It does 2.5× the world's share of Health Sciences.

Question 6

Is Affibody (Sweden)'s research output growing?

Accepted Answer

Output in 2022-2025 was 139% higher than in 2018-2021.